ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Deep Budget Cuts Poised to Kick in March 1; Hill Insiders See Little Hope for Deal

February 15, 2013

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990

In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced

July 3, 1981

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

DeVita Says NCAB Subcommittee’s Recommendation For Reshaping Organ Site Program Is “Reasonable”

April 23, 1982